Gilead Sciences (GILD) stock

Last close 170.87 USD (Nov 10, 2026), on the day +0.9 %.

• Sector: Healthcare, Drug Manufacturers - General.
• Market cap: 210.0B USD.
• Dividend yield: 1.97 %.
• Over 52 weeks: low 118.15 USD, high 174.48 USD, price change +44.6 %.
• Analysts' average 12-month target from Yahoo Finance: 175 USD (26 analysts). Not our estimate.

Earnings

• Feb 9, 2027: EPS not yet, estimate 1.09
• Oct 29, 2026: EPS 2.55, estimate 2.19
• Aug 4, 2026: EPS −6.75, estimate −7.25
• May 7, 2026: EPS 2.03, estimate 1.91
• Feb 10, 2026: EPS 1.86, estimate 1.81
• Oct 30, 2025: EPS 2.47, estimate 2.14

Which large investors hold it

• Dodge & Cox – 1.6 % of the portfolio
• Ray Dalio – 0.2 % of the portfolio

In baskets

• Pharma

Similar companies: ABBV · AMGN · AZN · BIIB · BMY · GSK · JNJ · LLY · MRK · NOVN.SW · NVO · PFE